Erste Asset Management’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $279K | Hold |
|
|||||
|
2025
Q1 | $223K | Hold |
|
|||||
|
2024
Q4 | $340K | Hold |
|
|||||
|
2024
Q3 | $1.17M | Hold |
|
|||||
|
2024
Q2 | $933K | Hold |
|
|||||
|
2024
Q1 | $1.34M | Buy |
|
|||||
|
2023
Q4 | $234K | Hold |
|
|||||
|
2023
Q3 | $186K | Hold |
|
|||||
|
2023
Q2 | $227K | Hold |
|
|||||
|
2023
Q1 | $240K | Hold |
|
|||||
|
2022
Q4 | $274K | Hold |
|
|||||
|
2022
Q3 | $207K | Hold |
|
|||||
|
2022
Q2 | $155K | Hold |
|
|||||
|
2022
Q1 | $306K | Hold |
|
|||||
|
2021
Q4 | $318K | Hold |
|
|||||
|
2021
Q3 | $234K | Hold |
|
|||||
|
2021
Q2 | $242K | Hold |
|
|||||
|
2021
Q1 | $328K | Hold |
|
|||||
|
2020
Q4 | $425K | Buy |
|